Question

Which of the following is the first level of biocompatibility testing?

• A. Secondary test
• B. In vitro test
• C. Clinical trial
• D. In vivo animal model test

Hint:

To remember this testing sequence easily, follow the logical progression of life complexity: $\mathbf{\textit{In vitro}\text{ (Cells in dish)}} \longrightarrow \mathbf{\textit{In vivo}\text{ (Animal models)}} \longrightarrow \mathbf{\text{Clinical Trials (Human patients)}}$ Always test on isolated cells first before introducing a material to a living organism!

Answer 1

The Correct Option is B

Concept: Biocompatibility evaluation follows a strict hierarchical testing pipeline designed to maximize safety, minimize cost, and maintain ethical boundaries before any medical implant reaches human patients.

Step 1: Reviewing the sequential tiers of biological safety testing.
The medical device screening pathway follows an ordered sequence:
• Tier 1: In vitro testing (First Level): These are laboratory test tubes or petri dish assays performed outside a living organism. They expose cell cultures directly to the biomaterial (e.g., cytotoxicity, cell adhesion assays). They are fast, cost-effective, and highlight immediate toxic hazards without sacrificing animal lives.
• Tier 2: In vivo animal models: If the material passes in vitro steps, it advances to living animal tissue models (rats, rabbits) to study complex systemic immune responses, inflammation, and tissue integration.
• Tier 3: Clinical Trials (Final Level): Human patient evaluation to confirm absolute therapeutic efficacy and long-term safety under actual clinical conditions.

Step 2: Identifying the absolute first entry step.
Because in vitro testing sits at the foundational baseline of this testing sequence, it serves as the definitive first level of biocompatibility validation. This corresponds to Option (B).